Display options
Cite
Jaffary F, Faghihi G, Mokhtarian A, et al. Effects of oral vitamin E on treatment of atopic dermatitis: A randomized controlled trial. J Res Med Sci. 2015;20(11):1053-7doi: 10.4103/1735-1995.172815.
Jaffary, F., Faghihi, G., Mokhtarian, A., & Hosseini, S. M. (2015). Effects of oral vitamin E on treatment of atopic dermatitis: A randomized controlled trial. Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences, 20(11), 1053-7. https://doi.org/10.4103/1735-1995.172815
Jaffary, Fariba, et al. "Effects of oral vitamin E on treatment of atopic dermatitis: A randomized controlled trial." Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences vol. 20,11 (2015): 1053-7. doi: https://doi.org/10.4103/1735-1995.172815
Jaffary F, Faghihi G, Mokhtarian A, Hosseini SM. Effects of oral vitamin E on treatment of atopic dermatitis: A randomized controlled trial. J Res Med Sci. 2015 Nov;20(11):1053-7. doi: 10.4103/1735-1995.172815. PMID: 26941808; PMCID: PMC4755091.
Copy Download .nbib Format: NLM
Share it on

J Res Med Sci. 2015 Nov;20(11):1053-7. doi: 10.4103/1735-1995.172815.

Effects of oral vitamin E on treatment of atopic dermatitis: A randomized controlled trial.

Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences

Fariba Jaffary, Gita Faghihi, Arghavan Mokhtarian, Sayed Mohsen Hosseini

Affiliations

  1. Department of Dermatology, School of Health, Skin Diseases and Leishmaniasis Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.
  2. Skin and Stem Cell Research Center, Tehran University of Medical Sciences, Tehran, Iran.
  3. Department of Biostatistics and Epidemiology, School of Health, Skin Diseases and Leishmaniasis Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.

PMID: 26941808 PMCID: PMC4755091 DOI: 10.4103/1735-1995.172815

Abstract

BACKGROUND: The pathogenesis of atopic dermatitis (AD) remains to be determined; recently a possible change in the immune system with production of immunoglobulins is proposed. As vitamin E is a potent antioxidant, with the ability to decrease the serum levels of immunoglobulin E (IgE) in atopic patients, we aimed to evaluate the effect of oral vitamin E on treatment of AD.

MATERIALS AND METHODS: This randomized, double-blind, placebo-controlled trial comprised seventy participants with mild-to-moderate AD, based on the Hanifin and Rajka diagnostic criteria. The patients were randomly selected from teaching skin clinics in Isfahan, Iran. They were randomly assigned to two groups of equal number, receiving vitamin E (400 IU/day) and placebo for four 4 months. Each month, the extent, severity, and subjective symptoms including itch and sleeplessness were measured by SCORAD index. Three months after the end of intervention, the recurrence rate was assessed.

RESULTS: The improvement in all symptoms, except sleeplessness, was significantly higher in the group receiving vitamin E than in controls (-1.5 vs. 0.218 in itching, -10.85 vs. -3.54 in extent of lesion, and -11.12 vs. -3.89 in SCORAD index, respectively, P < 0.05). Three months after the end of intervention, the recurrence rate of AD was evaluated. Recurrence rate between all 42 individuals, who remained in the study, was 18.6%. Recurrence ratio of the group receiving vitamin E compared to the placebo group was 1.17, without significant differences between the two groups (P > 0.05).

CONCLUSION: This study suggests that vitamin E can improve the symptoms and the quality of life in patients with AD. As vitamin E has no side effects with a dosage of 400 IU/day, it can be recommended for the treatment of AD.

Keywords: Atopic dermatitis (AD); SCORAD index; treatment; vitamin E

References

  1. Dermatology. 1994;189(1):38-40 - PubMed
  2. Am J Clin Dermatol. 2003;4(12):833-42 - PubMed
  3. Int J Dermatol. 2002 Mar;41(3):146-50 - PubMed
  4. Allergy. 2006 Dec;61(12):1397-402 - PubMed
  5. Mol Aspects Med. 2007 Oct-Dec;28(5-6):646-67 - PubMed
  6. N Engl J Med. 2005 Jun 2;352(22):2314-24 - PubMed
  7. Arch Dermatol Forsch. 1973 May 28;246(4):209-302 - PubMed
  8. Vet Dermatol. 2002 Dec;13(6):301-5 - PubMed
  9. Trends Immunol. 2007 Jul;28(7):294-8 - PubMed
  10. Aviat Space Environ Med. 2007 Jan;78(1):29-37 - PubMed
  11. Allergy. 1998 Dec;53(12):1202-7 - PubMed
  12. J Invest Dermatol. 2007 Jun;127(6):1282-4 - PubMed
  13. Annu Rev Nutr. 2007;27:347-62 - PubMed
  14. J Dermatol Sci. 2001 Apr;25(3):171-8 - PubMed
  15. Dermatology. 1993;186(1):23-31 - PubMed
  16. Expert Opin Pharmacother. 2004 Mar;5(3):643-55 - PubMed
  17. J Allergy Clin Immunol. 2000 Feb;105(2 Pt 1):353-7 - PubMed
  18. Br J Dermatol. 2005 Jun;152(6):1161-4 - PubMed
  19. Life Sci. 2003 Apr 18;72(22):2509-16 - PubMed
  20. Lancet. 2000 Nov 4;356(9241):1573-4 - PubMed
  21. Int J Clin Pract. 2006 Aug;60(8):984-92 - PubMed
  22. Dermatology. 1997;195(1):10-9 - PubMed
  23. Psychother Psychosom. 2001 May-Jun;70(3):118-36 - PubMed
  24. Int J Dermatol. 1987 Jan-Feb;26(1):27-32 - PubMed
  25. Br J Dermatol. 2005 Jun;152(6):1282-9 - PubMed

Publication Types